The Scientist

» FDA and developmental biology

Most Recent

image: Drugs OKed Faster in U.S. Than in Europe

Drugs OKed Faster in U.S. Than in Europe

By | April 10, 2017

In recent years, the US Food and Drug Administration has approved more drugs and in less time than the European Medicines Agency.

0 Comments

23andMe customers can now receive information about genetic risk for diseases including Parkinson’s and celiac.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | April 1, 2017

Eugene Garfield, the cancer moonshot, employee genetic testing, and more

0 Comments

image: Image of the Day: Tubular Origins

Image of the Day: Tubular Origins

By | March 23, 2017

Murine neural tubes, with each image highlighting a different embryonic tissue type (blue). The neural tube itself (left) grows into the brain, spine, and nerves, while the mesoderm (middle) develops into other organs, and the ectoderm (right) forms skin, teeth, and hair.

0 Comments

image: Scott Gottlieb Nominated to Lead the FDA

Scott Gottlieb Nominated to Lead the FDA

By | March 13, 2017

President Donald Trump has nominated physician Scott Gottlieb to be the next FDA commissioner.

0 Comments

Researchers report growing a mouse embryo using two types of early stem cells.

0 Comments

image: Infant Brain Scans May Predict Autism Diagnosis

Infant Brain Scans May Predict Autism Diagnosis

By | February 17, 2017

A computer algorithm can identify the brains of autism patients with moderate accuracy based on scans taken at six months and one year of age.

0 Comments

image: Tom Price Confirmed as HHS Director

Tom Price Confirmed as HHS Director

By | February 10, 2017

The orthopedic surgeon is confirmed to lead the US Department of Health and Human Services.

2 Comments

A conversation with public health expert Lynn Goldman, a former assistant administrator at the US Environmental Protection Agency

1 Comment

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Studies Retracted After UCLA Investigation
  4. Trump Nominates Sam Clovis to Lead USDA Research
AAAS